Form 4: Tandem Diabetes Care CTO Reports Routine Stock Vesting and Tax Withholding

Tandem Diabetes Care Inc.'s Chief Technology Officer, Rick Carpenter, reported the vesting of restricted stock units and subsequent share withholding for tax obligations on June 16, 2025.

Summary

• Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care Inc. (TNDM), reported transactions on June 16, 2025.
• The transactions involved the vesting of 406 Restricted Stock Units (RSUs) into common stock.
• Concurrently, 207 shares of common stock were disposed of (withheld by the company) to satisfy tax withholding requirements related to the RSU vesting.
• The price per share for the tax withholding was $20.76.
• Following these transactions, Mr. Carpenter directly beneficially owns 21,219 shares of common stock.
• Additionally, Mr. Carpenter holds 812 derivative securities in the form of Restricted Stock Units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary insider transaction (RSU vesting and tax withholding) that does not indicate any specific positive or negative operational or financial developments for the company.

Positives

• The vesting of Restricted Stock Units represents a realization of compensation for the Chief Technology Officer, indicating continued executive alignment with shareholder interests through equity ownership.

Negatives

• 207 shares of common stock were withheld by the company to cover tax obligations, resulting in a slight reduction in the direct beneficial ownership of common stock following the RSU vesting.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook. It solely reports an insider's stock transactions.

Industry Context

This filing is a routine insider transaction report and does not provide information that directly relates to broader industry trends or competitive dynamics within the diabetes care sector. It reflects standard executive compensation practices.

Stakeholder Impact

• Shareholders: The transaction represents a routine compensation event for a key executive, which is part of the company's established incentive plans. It does not indicate any significant change in company strategy or financial health.
• Employees: No direct impact on employees beyond the executive compensation structure.

Next Steps

• The remaining Restricted Stock Units (RSUs) held by Rick Carpenter are scheduled to vest in twelve equal quarterly installments following the initial 25% vesting on December 15, 2022.

Key Dates

Keywords

Tandem Diabetes Care, TNDM, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership, Chief Technology Officer